NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
1-Year Return
12.08%
This Quarter Return
-13.22%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$2.03B
AUM Growth
+$135M
(+7.1%)
Cap. Flow
+$443M
Cap. Flow
% of AUM
21.79%
Top 10 Holdings %
Top 10 Hldgs %
63.8%
Holding
57
New
6
Increased
19
Reduced
9
Closed
3
Top Buys
| 1 |
Stryker
SYK
|
$159M |
| 2 |
Steris
STE
|
$96.4M |
| 3 |
Corcept Therapeutics
CORT
|
$60.1M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$38.7M |
| 5 |
Cable One
CABO
|
$36.9M |
Top Sells
| 1 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$23.2M |
| 2 |
Apple
AAPL
|
$20.4M |
| 3 |
Inogen
INGN
|
$14.7M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$13.9M |
| 5 |
Nkarta
NKTX
|
$7.56M |
Sector Composition
| 1 | Healthcare | 58.54% |
| 2 | Technology | 15.07% |
| 3 | Financials | 6.4% |
| 4 | Communication Services | 2.82% |
| 5 | Consumer Discretionary | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRTX
51
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $3.2M | 0.16% |
2,459,021
| – | – |
|
|
VRNA
52
Verona Pharma
VRNA
$9.19B
| $3.19M | 0.16% |
761,205
| – | – |
|
53
Aligos Therapeutics
ALGS
$74.7M
| $2.36M | 0.12% |
78,000
| – | – |
|
54
Spero Therapeutics
SPRO
$120M
| $347K | 0.02% |
468,902
| – | – |
|
|
55
Iovance Biotherapeutics
IOVA
$796M
| – | – |
-836,518
| Closed | -$13.9M |
|
56
Praxis Precision Medicines
PRAX
$970M
| – | – |
-16,667
| Closed | -$2.55M |
|
|
CMPI
57
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| – | – |
-2,161,990
| Closed | -$6.9M |
|